CIK 0001130166 · Non-accelerated filer<br>Smaller reporting company
Bio Green Med Solution, Inc.
Sign in to watch- Tickers
- BGMS BGMSP
- Exchange
- Nasdaq, OTC
- Industry
- Wholesale-Durable Goods, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911766850
- Phone
- 908-517-7330
- Business address
- 200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Cyclacel Pharmaceuticals, Inc., XCYTE THERAPIES INC
Securities
- BGMS Common Stock Nasdaq
- BGMSP Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 99 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-14 | Spiegel Robert J. Director | Grant or award | +15,822 | 18,196 | ||
| 2022-06-14 | Spiegel Robert J. Director | Grant or award · Stock Option (right to buy) | +31,645 | 31,645 | ||
| 2022-06-14 | Sems Lloyd Director | Grant or award | +15,822 | 18,196 | ||
| 2022-06-14 | Sems Lloyd Director | Grant or award · Stock Option (right to buy) | +31,645 | 31,645 | ||
| 2022-06-14 | SCHWARTZ BRIAN Director | Grant or award | +15,822 | 19,383 | ||
| 2022-06-14 | SCHWARTZ BRIAN Director | Grant or award · Stock Option (right to buy) | +31,645 | 31,645 | ||
| 2022-06-14 | HENNEY CHRISTOPHER S Director | Grant or award | +15,822 | 18,196 | ||
| 2022-06-14 | HENNEY CHRISTOPHER S Director | Grant or award · Stock Option (right to buy) | +31,645 | 31,645 | ||
| 2022-06-14 | BARKER SAM L Director | Grant or award | +15,822 | 19,196 | ||
| 2022-06-14 | BARKER SAM L Director | Grant or award · Stock Option (right to buy) | +31,645 | 31,645 | ||
| 2021-12-13 | Rombotis Spiro George President and CEO | Grant or award · Stock Option (right to buy) | +190,000 | 190,000 | ||
| 2021-12-13 | Rombotis Spiro George President and CEO | Grant or award · Stock Option (right to buy) | +190,000 | 190,000 | ||
| 2021-12-13 | McBarron Paul See Remarks | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2021-12-13 | Kirschbaum Mark Chief Medical Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2021-11-30 | BARKER SAM L Director | Sale | −12 | $3.57 | $43 | 3,374 |
| 2021-11-18 | Rombotis Spiro George President and CEO | Purchase | +4,000 | $4.50 | $18K | 4,988 |
| 2021-08-24 | BARKER SAM L Director | Purchase | +1,000 | $5.00 | $5K | 3,386 |
| 2021-06-15 | Hradsky Gregory T. Director | Grant or award | +2,374 | 2,374 | ||
| 2021-06-15 | Hradsky Gregory T. Director | Grant or award · Stock Option (right to buy) | +4,748 | 4,748 | ||
| 2021-06-15 | BARKER SAM L Director | Grant or award | +2,374 | 2,386 |
Page 5 of 24 · 475 trades